pharmalot· @pharmalot · X·· 2 天前AI 评分20
AI 导读
Pharmalot.. Pharmalittle.. 早安：我们正在阅读关于 GLP-1 成为生活方式药物、默沙东和第一三共遭遇挫折，以及更多新闻.. https://www.statnews.com/pharmalot/2026/09/28/glp1-lifestyle-drug-marketing-merck-daiichi-lung-cancer-setback/ #pharma #GLP #weight #obesity #cancer #patent #India #Merck #Roche #flu #pandemic #AbbVie #Novo #UK #Trump
正文
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more news.. https://www.statnews.com/pharmalot/2026/09/28/glp1-lifestyle-drug-marketing-merck-daiichi-lung-cancer-setback/ #pharma #GLP #weight #obesity #cancer #patent #India #Merck #Roche #flu #pandemic #AbbVie #Novo #UK #Trump
来源：pharmalot · x.com